View in EDS

1487P Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer: Updated results.

Saved in:
Bibliographic Details
Title: 1487P Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer: Updated results.
Authors: Wang, Q.1 (AUTHOR), Xu, A.2 (AUTHOR), Ma, C.3 (AUTHOR), Wang, T.4 (AUTHOR), Liu, P.5 (AUTHOR), Duan, Y.6 (AUTHOR), Kong, T.7 (AUTHOR), Chen, G.8 (AUTHOR), Jia, X.9 (AUTHOR), Shang, K.10 (AUTHOR), Yang, G.11 (AUTHOR), Zhang, G.12 (AUTHOR), Yu, F.13 (AUTHOR), Wang, H.14 (AUTHOR), Chen, H.15 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS840-S840. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 173099242
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1487P Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer: Updated results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Q%2E%22">Wang, Q.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+A%2E%22">Xu, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+C%2E%22">Ma, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+T%2E%22">Wang, T.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+P%2E%22">Liu, P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duan%2C+Y%2E%22">Duan, Y.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kong%2C+T%2E%22">Kong, T.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+G%2E%22">Chen, G.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jia%2C+X%2E%22">Jia, X.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shang%2C+K%2E%22">Shang, K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+G%2E%22">Yang, G.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+G%2E%22">Zhang, G.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+F%2E%22">Yu, F.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+H%2E%22">Wang, H.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+H%2E%22">Chen, H.</searchLink><relatesTo>15</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS840-S840. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.09.2518
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S840
    Titles:
      – TitleFull: 1487P Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer: Updated results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Q.
      – PersonEntity:
          Name:
            NameFull: Xu, A.
      – PersonEntity:
          Name:
            NameFull: Ma, C.
      – PersonEntity:
          Name:
            NameFull: Wang, T.
      – PersonEntity:
          Name:
            NameFull: Liu, P.
      – PersonEntity:
          Name:
            NameFull: Duan, Y.
      – PersonEntity:
          Name:
            NameFull: Kong, T.
      – PersonEntity:
          Name:
            NameFull: Chen, G.
      – PersonEntity:
          Name:
            NameFull: Jia, X.
      – PersonEntity:
          Name:
            NameFull: Shang, K.
      – PersonEntity:
          Name:
            NameFull: Yang, G.
      – PersonEntity:
          Name:
            NameFull: Zhang, G.
      – PersonEntity:
          Name:
            NameFull: Yu, F.
      – PersonEntity:
          Name:
            NameFull: Wang, H.
      – PersonEntity:
          Name:
            NameFull: Chen, H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2023 Supplement 2
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1